Tetrodecadazinone, a novel tetrodecamycin-pyridazinone hybrid with anti-liver fibrosis activity from Streptomyces sp. HU051

Ruo-Xi Liu,Shi-Fan Ma,Yi-Li Chen,Lie-Feng Ma,Ji-Dong Wang,Zha-Jun Zhan,Ruo-Xi Liu,Shi-Fan Ma,Yi-Li Chen,Lie-Feng Ma,Ji-Dong Wang,Zha-Jun Zhan
DOI: https://doi.org/10.1016/j.bioorg.2021.105573
IF: 5.307
2022-02-01
Bioorganic Chemistry
Abstract:Tetrodecadazinone (1), a novel tetrodecamycin-pyridazinone hybrid possessing a new 1,2-dimethyl-1-(2-methylnonyl)decahydronaphthalene skeleton, and 4-hydroxydihydrotetrodecamycin (2) were separated from a culture of Streptomyces sp. HU051, together with a known compound, dihydrotetrodecamycin (3). Diverse spectroscopic approaches were applied to assign the structures of 1-3, and the structure of 1 was further confirmed by single crystal X-ray diffraction analysis. Compound 1 is the first example of a pyridazinone-containing natural product. Biosynthetically, 1 is proposed to be derived from a Michael addition reaction of a PKS-derived tetrodecamycin and a piperazic-acid-derived pyridazinone. Biological evaluation revealed 1 could reduce the expressions of extracellular matrix proteins (fibronectin and collagen I) and α-smooth muscle actin (α-SMA) in transforming growth factor-β (TGF-β1)-activated LX-2 cells. Preliminary mechanism study showed 1 exerted its anti-liver fibrosis effect by regulating TGF-β1/Smad2/3 signaling pathway.
biochemistry & molecular biology,chemistry, organic
What problem does this paper attempt to address?